These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2183731)

  • 1. Serologic tests for Lyme disease. Interlaboratory variability.
    Luger SW; Krauss E
    Arch Intern Med; 1990 Apr; 150(4):761-3. PubMed ID: 2183731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory diagnosis of Lyme disease.
    Magnarelli LA
    Rheum Dis Clin North Am; 1989 Nov; 15(4):735-45. PubMed ID: 2685928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of borreliacidal antibodies by flow cytometry. An accurate, highly specific serodiagnostic test for Lyme disease.
    Callister SM; Schell RF; Lim LC; Jobe DA; Case KL; Bryant GL; Molling PE
    Arch Intern Med; 1994 Jul; 154(14):1625-32. PubMed ID: 8031211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class-specific and polyvalent enzyme-linked immunosorbent assays for detection of antibodies to Borrelia burgdorferi in equids.
    Magnarelli LA; Anderson JF
    J Am Vet Med Assoc; 1989 Nov; 195(10):1365-8. PubMed ID: 2684937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serologic evaluation of occurrence in Poland of Lyme disease caused by infection with Borrelia burgdorferi].
    Tylewska-Wierzbanowska S; Kruszewska D
    Med Dosw Mikrobiol; 1993; 45(4):487-91. PubMed ID: 8189829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody testing in Lyme disease. A comparison of results in four laboratories.
    Schwartz BS; Goldstein MD; Ribeiro JM; Schulze TL; Shahied SI
    JAMA; 1989 Dec 22-29; 262(24):3431-4. PubMed ID: 2685383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
    Lebech AM
    APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problems in the use of serologic tests for the diagnosis of Lyme disease.
    Corpuz M; Hilton E; Lardis MP; Singer C; Zolan J
    Arch Intern Med; 1991 Sep; 151(9):1837-40. PubMed ID: 1888250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology.
    Bakken LL; Case KL; Callister SM; Bourdeau NJ; Schell RF
    JAMA; 1992 Aug; 268(7):891-5. PubMed ID: 1640618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proficiency testing program for Lyme disease.
    Seder RH; Berardi VP
    Arch Pathol Lab Med; 1996 Apr; 120(4):323-5. PubMed ID: 8619739
    [No Abstract]   [Full Text] [Related]  

  • 11. Serological responses in Lyme disease: the influence of sex, age, and environment.
    Fidelus-Gort R; Gilmour RW; Kashatus WC
    Ann Clin Lab Sci; 1993; 23(3):221-9. PubMed ID: 8323257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serodiagnosis of Lyme borreliosis using detection of different immunoglobulin (sub)classes by enzyme-linked immunosorbent assay and Western blotting.
    Goossens HA; van den Bogaard AE; Nohlmans MK
    Clin Lab; 2001; 47(1-2):41-9. PubMed ID: 11214222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis].
    Zajkowska JM; Kondrusik M; Pancewicz SA; Grygorczuk S; Jamiołkowski J; Stalewska J
    Pol Merkur Lekarski; 2007 Aug; 23(134):95-9. PubMed ID: 18044336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of tests for detection of Borrelia burgdorferi sensu lato infection in patients with diagnosed borreliosis.
    Chmielewska-Badora J; Cisak E; Wójcik-Fatla A; Zwoliński J; Buczek A; Dutkiewicz J
    Ann Agric Environ Med; 2006; 13(2):307-11. PubMed ID: 17196006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans.
    Merljak Skocir L; Ruzić-Sabljić E; Maraspin-Carman V; Lotric-Furlan S; Logar M; Strle F
    Int J Med Microbiol; 2008 Jul; 298(5-6):493-504. PubMed ID: 17892971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of a proficiency testing program for Lyme disease in New York State.
    Dayian G; Morse DL; Schryver GD; Stevens RW; Birkhead GS; White DJ; Hechemy KE
    Arch Pathol Lab Med; 1994 May; 118(5):501-5. PubMed ID: 8192559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.
    Hunfeld KP; Ernst M; Zachary P; Jaulhac B; Sonneborn HH; Brade V
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):580-5. PubMed ID: 12422605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and diagnosis of Lyme borreliosis.
    Wilske B
    Ann Med; 2005; 37(8):568-79. PubMed ID: 16338759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Laboratory diagnosis of infection caused by Borrelia burgdorferi].
    Dessau RB; Bangsborg JM; Jensen TP; Hansen K; Lebech AM; Andersen CØ
    Ugeskr Laeger; 2006 Aug; 168(34):2805-7. PubMed ID: 16942701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serological screening for Lyme disease in Israel].
    Kletter Y; Berger SA
    Harefuah; 1993 Nov; 125(9):261-3, 328. PubMed ID: 8253415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.